Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.33 |
| ▸ | AKR1B1 | P15121 | 4/20 | 0.33 |
| ▸ | ERN1 | O75460 | 4/20 | 0.33 |
| ▸ | LCK | P06239 | 1/20 | 0.33 |
| ▸ | GLA | P06280 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.33 |
| ▸ | LIMK2 | P53671 | 1/20 | 0.33 |
| ▸ | TUBB1 | Q9H4B7 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13664201 | 0.80 | LMNA (0.34) | ALDH1A1TUBB1 | |
| SCHEMBL364732 | 0.77 | ALDH1A1 (0.44) | ALDH1A1AKR1B1ERN1LCKGLA | |
| SCHEMBL4302103 | 0.75 | TUBB1 (0.33) | PTGS2TUBB1 | |
| SCHEMBL11928778 | 0.71 | SMN1; SMN2 (0.38) | ALDH1A1MAPT | |
| SCHEMBL20561607 | 0.70 | ALDH1A1 (0.42) | ALDH1A1ERN1MAPTTUBB1 | |
| SCHEMBL4300317 | 0.70 | PDE3B (0.38) | PTGS2AKR1B1MAPT | |
| SCHEMBL30699313 | 0.70 | PDE3B (0.38) | PTGS2AKR1B1MAPT | |
| SCHEMBL4303270 | 0.70 | — | — | |
| SCHEMBL13664486 | 0.70 | — | — | |
| SCHEMBL20524579 | 0.69 | ALDH1A1 (0.38) | ALDH1A1AKR1B1ERN1LCKGLA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090270614-A1 | OPTICALLY ACTIVE QUATERNARY AMMONIUM SALT HAVING AXIAL ASYMMETRY AND PROCESS FOR PRODUCING ALPHA-AMINO ACID AND DERIVATIVE THEREOF WITH THE SAME | NAGASE & CO., LTD. (JP) | 2009-10-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090270614-A1 | OPTICALLY ACTIVE QUATERNARY AMMONIUM SALT HAVING AXIAL ASYMMETRY AND PROCESS FOR PRODUCING ALPHA-AMINO ACID AND DERIVATIVE THEREOF WITH THE SAME | BCAT1, BCAT2, AADAT | ALDH1A1 837/4885PTGS2 4008/4885AKR1B1 390/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.